
Solara Active Pharma Sciences Ltd. (SOLARA): Solara Active Pharma Sciences Share Price Near 52-Week High
Updated: 29 Sept 2026 • 11:54 am
Posted by:

Solara Active Pharma Sciences Share Price is trading at Rs 766.7, up 4% on the day, and is sitting close to its 52-week high. The company’s market capitalisation stands at Rs 3,556.79 Cr, which places the move in a clear price context for Solara Active Pharma Sciences Share Price Today. The latest Univest data confirms the stock is trading near a yearly high, but it does not establish a company-specific trigger for the move. For readers tracking Solara Active Pharma Sciences Stock News, the key point is the position of the current price against the day’s high, the previous close, and the broader valuation backdrop.
Univest is following Solara Active Pharma Sciences Share Price as a near-52-week-high event because the stock is moving within a narrow band of its one-year high. The session started at Rs 729.15, the same level as the day’s low, and the stock touched Rs 768 during the session. That keeps Solara Active Pharma Sciences Share Price Today firmly in focus for market watchers looking at the latest Share Price Update, especially as the company also carries a detailed fundamentals profile that can be compared with its Healthcare peer set.
Solara Active Pharma Sciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 766.7 |
| Previous Close | Rs 737.2 |
| Today's Move | +Rs 29.5 (+4%) |
| Open | Rs 729.15 |
| High | Rs 768 |
| Low | Rs 729.15 |
| Market Capitalisation | Rs 3,556.79 crore |
Solara Active Pharma Sciences Ltd. (SOLARA) traded at Rs 766.7 versus the previous close of Rs 737.2, a rise of 4%. The stock opened at Rs 729.15, reached a high of Rs 768 and touched a low of Rs 729.15.
Solara Active Pharma Sciences Share Price was last traded at Rs 766.7 versus the previous close of Rs 737.2, a day move of Rs 29.5 or 4%. The stock opened at Rs 729.15 and moved between Rs 729.15 and Rs 768 during the session, leaving it just Rs 1.3 below the 52-week high. For Solara Active Pharma Sciences Share Price Today, that means the stock is trading very close to its yearly high without any claim that the level has been broken. Univest also notes that the move is measurable against the prior close, which helps frame Solara Active Pharma Sciences Stock News in a strictly factual way. For readers scanning Share Market Today and Market News, the price action is the central development.
The move is also relevant because Solara Active Pharma Sciences Share Price has stayed within a tight gap of its one-year high while holding above the opening level. That makes the stock one of the names to watch among stocks in news and 52 Week High Stocks today, even as the latest data does not identify a specific catalyst. Investors following Solara Active Pharma Sciences Share Price Update can therefore focus on the actual price print, the day’s range and the relation to the yearly high rather than assumptions about why the move happened. That is the cleanest reading of the session for Univest readers.
Solara Active Pharma Sciences Ltd. (SOLARA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 3,556.79 crore |
| P/E Ratio | 61.94x |
| P/B Ratio | 2.8x |
| ROE | -0.63% |
| ROCE | 4.61% |
| EPS | Rs -0.34 |
| Book Value Per Share | Rs 263.29 |
| Dividend Yield | 0% |
Solara Active Pharma Sciences Ltd. (SOLARA) fundamental metrics show P/E 61.94x, P/B 2.8x, ROE -0.63%, ROCE 4.61%. These figures provide context only and are not a buy or sell signal.
Solara Active Pharma Sciences Ltd. has a market capitalisation of Rs 3556.79 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 61.94x, P/B at 2.8x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -0.63% and ROCE of 4.61%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -0.34, book value per share of Rs 263.29, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.3x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 61.94x |
| Benchmark Median P/E | 28.3x |
| Benchmark Average P/E | 41.83x |
| Benchmark P/E Range | 0x to 707.31x |
| Company P/B Ratio | 2.8x |
| Benchmark Median P/B | 2.88x |
| Company ROE | -0.63% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | 4.61% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 3,556.79 crore |
| Benchmark Median Market Cap | Rs 782.41 crore |
Solara Active Pharma Sciences Ltd. (SOLARA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Solara Active Pharma Sciences Ltd. (SOLARA) has a P/E ratio of 61.94x, which is above the benchmark median of 28.3x, a difference of +118.87%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Solara Active Pharma Sciences Ltd. (SOLARA) has a ROE of -0.63%, which is below the benchmark median of 11.74%, a difference of -105.37%. Solara Active Pharma Sciences Ltd. (SOLARA) has a ROCE of 4.61%, which is below the benchmark median of 13.63%, a difference of -66.18%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 3,518.03 | 61.94 | 2.52 | 3.47 | 4 |
| Kwality Pharmaceuticals Ltd. | KPL | 3,809.57 | 45.84 | 10.42 | 22.67 | 24.01 |
| Unichem Laboratories Ltd. | UNICHEMLAB | 3,873.72 | 12.41 | 1.37 | 9.81 | 10.68 |
| Advanced Enzyme Technologies Ltd. | ADVENZYMES | 3,263.54 | 19.16 | 1.91 | 11.43 | 15.27 |
| Aarti Drugs Ltd. | AARTIDRUGS | 3,922.33 | 20.48 | 2.45 | 13.36 | 12.04 |
Solara Active Pharma Sciences Ltd. (SOLARA) has a P/E ratio of 61.94x compared with the displayed peer median of 20.48x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.63% compares with a peer median of 11.43% across the companies shown in the table. ROCE stood at 4.61% versus the displayed peer median of 12.04%, providing a capital-efficiency comparison. Solara Active Pharma Sciences Ltd. (SOLARA) has a market capitalisation of Rs 3,556.79 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Solara Active Pharma Sciences
- Solara Active Pharma Sciences Share Price is trading at Rs 766.7, only Rs 1.3 below its 52-week high.
- Solara Active Pharma Sciences Share Price Today is up 4% versus the previous close of Rs 737.2.
- The company’s market capitalisation stands at Rs 3,556.79 Cr.
- P/E is 61.94, P/B is 2.8, ROE is -0.63 and ROCE is 4.61.
- Revenue and profit figures for the latest quarters give Solara Active Pharma Sciences Fundamental Analysis a mixed reading.
About Solara Active Pharma Sciences
Solara Active Pharma Sciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The stock is tracked on NSE and BSE under the symbol SOLARA, and Univest classifies it through its stock detail page for readers following Solara Active Pharma Sciences Share Price, Solara Active Pharma Sciences Stock News and Solara Active Pharma Sciences Latest News. The company description available here is limited to its sector and industry classification, so the profile should be read strictly in that context. For a compact company overview, Univest focuses on the stated market data, valuation metrics and quarterly financial figures rather than broader business assumptions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Solara Active Pharma Sciences Share Price in focus today?
Ans. Solara Active Pharma Sciences Share Price is in focus because it is trading at Rs 766.7, very close to its 52-week high after rising 4% from the previous close.
What is Solara Active Pharma Sciences Share Price today?
Ans. Solara Active Pharma Sciences Share Price today is Rs 766.7. The stock moved up from the previous close of Rs 737.2 and stayed within a narrow band of the one-year high.
How far is Solara Active Pharma Sciences Share Price from its 52-week high?
Ans. Solara Active Pharma Sciences Share Price is Rs 1.3 below its 52-week high. That makes it a near-high move rather than a new high event.
What is the market cap of Solara Active Pharma Sciences?
Ans. Solara Active Pharma Sciences has a market capitalisation of Rs 3,556.79 Cr. That places it above the industry median market cap in the healthcare peer set shown here.
How does Solara Active Pharma Sciences compare on valuation?
Ans. Solara Active Pharma Sciences Share Price trades at a P/E of 61.94 and a P/B of 2.8. Its P/E is above the industry median, while P/B is close to the benchmark median.
What do the latest profitability numbers show for Solara Active Pharma Sciences?
Ans. Latest quarterly figures show revenue of Rs 3,816 in Jun 26 and net profit of Rs 163.1 in the same quarter. Earlier quarters included profit and loss swings, so the trend has not been linear.
How does Solara Active Pharma Sciences look against peers?
Ans. Solara Active Pharma Sciences Share Price sits near peers on market cap, but its ROE of -0.63 is weaker than the peer set listed here. ROCE at 4.61 is also below most comparable names.
Where can I track Solara Active Pharma Sciences Share Price updates?
Ans. Univest tracks Solara Active Pharma Sciences Share Price with live updates, valuation ratios, financial figures and peer comparisons. It is a useful place to follow the stock alongside its 52-week range and market cap context.
Track Solara Active Pharma Sciences Share Price on Univest
Use Solara Active Pharma Sciences Ltd. (SOLARA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Solara Active Pharma Sciences Share Price on Univest for live price updates, valuation ratios, the 52-week range, company financials, peer comparison and market insights. Univest also presents Solara Active Pharma Sciences Share Price Today alongside key market cap and fundamental metrics in one place.
Recent Articles

HCL Tech Q2 Dividend 2026: Rs 12 Per Share, 16 Oct Record Date, 26 Oct Payment Date, 95th Consecutive Quarter of Payouts, Dividend History, Yield Math and What Investors Must Know
12 October 2026

HCL Tech Q2 Result 2026, Dividend: PAT Jumps 21% to Rs 5,132 Crore, Revenue Up 11% at Rs 35,620 Crore, Rs 12 Dividend, Deal Wins, FY27 Guidance, AI Growth, Segments and What Investors Should Watch
12 October 2026

IPO Lock-In Expiry: $24 Billion Worth of Shares Set to Unlock on D-Street From Oct 2026 to Jan 2027, Nuvama Estimates 99 Companies, Promoter Holdings, Past Patterns and What Investors Must Know
12 October 2026

Small-Cap Stock Under Rs 20: Up 850% in 5 Years, Toll Fee Collector Stock Jumps 4.5% Despite Stock Market Sell-Off, What the 9.5x Return Means, Toll Sector Drivers and Risks of Low-Priced Stocks
12 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
HCL Tech Q2 Dividend 2026: Rs 12 Per Share, 16 Oct Record Date, 26 Oct Payment Date, 95th Consecutive Quarter of Payouts, Dividend History, Yield Math and What Investors Must Know
HCL Tech Q2 Result 2026, Dividend: PAT Jumps 21% to Rs 5,132 Crore, Revenue Up 11% at Rs 35,620 Crore, Rs 12 Dividend, Deal Wins, FY27 Guidance, AI Growth, Segments and What Investors Should Watch
IPO Lock-In Expiry: $24 Billion Worth of Shares Set to Unlock on D-Street From Oct 2026 to Jan 2027, Nuvama Estimates 99 Companies, Promoter Holdings, Past Patterns and What Investors Must Know
Small-Cap Stock Under Rs 20: Up 850% in 5 Years, Toll Fee Collector Stock Jumps 4.5% Despite Stock Market Sell-Off, What the 9.5x Return Means, Toll Sector Drivers and Risks of Low-Priced Stocks
Zetwerk IPO Valuation Targets Rs 25,583 Crore in Rs 5,012 Crore IPO: Price Band Rs 143 to Rs 151, Fresh Issue Rs 2,830 Crore, Revenue Rs 15,913 Crore, Losses, Use of Proceeds and What Investors Should Check

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





